ATE244017T1 - Antibordetella azellulärer impfstoff - Google Patents

Antibordetella azellulärer impfstoff

Info

Publication number
ATE244017T1
ATE244017T1 AT95402838T AT95402838T ATE244017T1 AT E244017 T1 ATE244017 T1 AT E244017T1 AT 95402838 T AT95402838 T AT 95402838T AT 95402838 T AT95402838 T AT 95402838T AT E244017 T1 ATE244017 T1 AT E244017T1
Authority
AT
Austria
Prior art keywords
antibordetella
acellular vaccine
bpp
immunogenic
acellular
Prior art date
Application number
AT95402838T
Other languages
English (en)
Inventor
Pascale Gueirard
Nicole Guiso
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE244017T1 publication Critical patent/ATE244017T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95402838T 1994-12-15 1995-12-15 Antibordetella azellulärer impfstoff ATE244017T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415137A FR2728170A1 (fr) 1994-12-15 1994-12-15 Vaccin de type acellulaire anti-bordetella

Publications (1)

Publication Number Publication Date
ATE244017T1 true ATE244017T1 (de) 2003-07-15

Family

ID=9469849

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95402838T ATE244017T1 (de) 1994-12-15 1995-12-15 Antibordetella azellulärer impfstoff

Country Status (10)

Country Link
US (5) US6387377B1 (de)
EP (2) EP1386616A1 (de)
JP (1) JPH10510984A (de)
AT (1) ATE244017T1 (de)
CA (1) CA2165393C (de)
DE (1) DE69531186T2 (de)
DK (1) DK0719560T3 (de)
ES (1) ES2202345T3 (de)
FR (1) FR2728170A1 (de)
WO (1) WO1996018414A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
ATE496634T1 (de) * 1995-05-04 2011-02-15 Sanofi Pasteur Ltd Azelluläre pertussis-impfstoffe und verfahren zu deren herstellung
FR2736064B1 (fr) * 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
DK1284993T3 (da) * 2000-05-25 2008-07-28 Pasteur Institut Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater
WO2009094006A2 (en) 2007-10-25 2009-07-30 Wake Forest University Health Sciences Bordetella outer-membrane protein antigens and methods of making and using the same
US20100112009A1 (en) * 2008-11-03 2010-05-06 Institut Pasteur Acellular antibordetella vaccine
BR112014017898B1 (pt) * 2012-02-01 2021-10-13 Glaxosmithkline Biologicals S.A. Processo de fermentação
EP2722338A1 (de) * 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Neue rekombinante Bordetella-Stämme
RU2540144C1 (ru) * 2013-12-11 2015-02-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) СПОСОБ ПОЛУЧЕНИЯ АНАТОКСИНА Bordetella pertussis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2606789B1 (fr) 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
EP0338170A1 (de) * 1988-04-19 1989-10-25 Institut Pasteur Immunschutz gewährendes antigenes Protein gegen pathogene Bakterien
EP0338169B1 (de) * 1988-04-19 1996-07-24 Institut Pasteur Verfahren zur Gewinnung von Schutzantigenen gegen Bordetella-Infektionen und toxische Prozesse
FR2638169B1 (fr) * 1988-10-25 1991-01-11 Pasteur Institut Derives d'adenyl cyclase et leurs utilisations biologiques
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
GB9115332D0 (en) * 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
JPH08500734A (ja) * 1992-08-18 1996-01-30 デュファル インターナショナル リサーチ ベスローテン フェンノートシャップ 気管支敗血症菌（Ｂｏｒｄｅｔｅｌｌａ ｂｒｏｎｃｈｉｓｅｐｔｉｃａ）ワクチン
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
US6030625A (en) * 1994-12-15 2000-02-29 Institut Pasteur Bordetella pertussis and Bordetella parapertussis strains
US5877159A (en) * 1995-05-03 1999-03-02 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same
US5877298A (en) * 1995-05-04 1999-03-02 Connaught Lab Acellular pertussis vaccines and methods of preparing thereof
FR2736064B1 (fr) * 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella

Also Published As

Publication number Publication date
US20030215461A1 (en) 2003-11-20
US6387377B1 (en) 2002-05-14
US20060073169A1 (en) 2006-04-06
EP0719560B1 (de) 2003-07-02
DE69531186D1 (de) 2003-08-07
DK0719560T3 (da) 2003-10-27
WO1996018414A1 (fr) 1996-06-20
FR2728170A1 (fr) 1996-06-21
AU715243B2 (en) 2000-01-20
CA2165393A1 (fr) 1996-06-16
US7465443B2 (en) 2008-12-16
US6582705B1 (en) 2003-06-24
US5985286A (en) 1999-11-16
EP1386616A1 (de) 2004-02-04
FR2728170B1 (de) 1997-02-28
ES2202345T3 (es) 2004-04-01
JPH10510984A (ja) 1998-10-27
AU4393596A (en) 1996-07-03
US7105317B2 (en) 2006-09-12
DE69531186T2 (de) 2004-04-22
EP0719560A1 (de) 1996-07-03
CA2165393C (fr) 2010-10-19

Similar Documents

Publication Publication Date Title
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
TW278099B (de)
NL300400I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
NZ513202A (en) Antigen composition comprising Bordetella bronchiseptica, formalin and glutaraldehyde
ES2114616T5 (es) Acidos dicarboxilicos alifaticos insaturados.
WO1998056901A3 (en) Live attenuated vaccines
ATE213005T1 (de) Kontinuierliches polymerisationverfahren von polyamiden
IL135743A0 (en) Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
ATE244017T1 (de) Antibordetella azellulärer impfstoff
DK0721506T3 (da) Bakterielle eksporterede proteiner og acellulære vacciner baseret derpå
EP0771214A4 (de) Behandlung und prävention von helicobacter-infektionen
ES2187648T3 (es) Metodo para la administracion de farmacos para terapia genica.
GB2288183B (en) Composition and method of preparing microemulsion blends
DK1154791T3 (da) Neisseria-vaccinesammensætninger og fremgangsmåder
ATE80179T1 (de) Modifiziertes pertussistoxin.
DK0840792T3 (da) (S)-hydroxynitrillyase fra Hevea brasiliensis
NL300336I1 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
DK0427462T3 (da) Fremgangsmåde
AUPP823999A0 (en) A treatment
SG90030A1 (en) Methods for producing enhanced antigenic helocobacter sp. and vaccines comprising same
AU5625796A (en) Protective epitopes of adenyl cyclase-haemolysin(AC-Hly), their application to the treatment or to the prevention of bordetella infections
ZA9710606B (en) Non-virulent Mycoplasma synoviae vaccine thereof.
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
ATE121423T1 (de) Impfstoff, geeignet für die bekämpfung von bordetella pertussis.
IL124354A0 (en) Hemoregulatory compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0719560

Country of ref document: EP